VERA
Vera Therapeutics Inc
NASDAQ: VERA · HEALTHCARE · BIOTECHNOLOGY
$35.84
-3.42% today
Updated 2026-04-29
Market cap
$2.57B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.66
Dividend yield
—
52W range
$19 – $56
Volume
1.2M
Vera Therapeutics Inc (VERA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-10.29M | $-34.81M | $-23.71M | $-67.60M | $-92.18M | $-134.68M | $-241.10M |
| Capital expenditures | $125000.00 | $99000.00 | $0.00 | $62000.00 | $63000.00 | $972000.00 | $630000.00 |
| Depreciation | $509000.00 | $251000.00 | $176000.00 | $-846000.00 | $-4.09M | $105000.00 | — |
| Stock-based comp | $263000.00 | $331000.00 | $3.01M | $8.89M | $11.49M | $20.80M | $37.93M |
| Free cash flow | $-10.41M | $-34.91M | $-23.71M | $-67.66M | $-92.24M | $-135.65M | $-241.73M |
| Investing cash flow | $-125000.00 | $-42000.00 | $-4.20M | $-70.55M | $-39.43M | $-425.03M | — |
| Financing cash flow | $-137000.00 | $85.29M | $53.88M | $101.93M | $133.54M | $606.67M | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | $25.97M | $-36.22M | — | — | — |